From extending lifespan to bolstering the immune system, the drug’s effects are only just beginning to be understood.
A new high-throughput, transcriptome-wide assay determines RNA structures in vivo.
June 1, 2015|
© GEORGE RETSECK
Like pieces of sticky tape, single-stranded RNA molecules can fold over and bind to themselves, via base pairing. Determining the complicated three-dimensional structures such folding creates can reveal the RNAs’ functions, but classic techniques for investigating molecular structure, such as X-ray crystallography, are “very laborious” in that they “can only be used on one RNA at a time,” says Howard Chang of Stanford University.
To study the secondary structures of multiple RNAs simultaneously, researchers have come up with chemical modification techniques that detect unpaired nucleotides in a pool of RNA molecules. Subsequent sequencing of the RNAs reveals the patterns of modified and unmodified bases (their unpaired or paired statuses) and thus indicates how each RNA molecule folds. One of these transcriptome-wide techniques, however, only targets two of the four nucleotides. And another targets all four nucleotides, but only works in vitro—where natural chemicals and proteins affecting structure are absent.
Chang and colleagues have now built upon the all-nucleotide modification technique—called selective 2'-hydroxyl acylation and profiling experiment (SHAPE)—to make it compatible with in vivo RNA analysis, and to allow for the enrichment of modified RNAs, thereby improving the signal-to-noise ratio. All in all, it means “we can now measure structural properties of RNAs at high resolution and very high throughput in their natural cellular context,” says Julius Lucks of Cornell University.
Additionally, by comparing how the modifications differ between RNAs inside cells and the same RNAs in vitro, Chang has been able to identify nucleotide sequences that are likely protein-binding sites. (Nature, 519:486-90, 2015)
|TECHNIQUE||CHEMICAL MODIFICATION||ENRICHMENT OF MODIFIED RNAs?||IN VIVO ANALYSIS||PROTEIN-BINDING ANALYSIS|
|DMS-seq||Dimethylsulphate modification of adenosines and cytosines only, with an almost 3:1 bias favoring adenosines||No||Yes||Possible in principle, but has not been done|
|In vivo click (ic) SHAPE||2-(azidomethyl)nicotinic acid acyl imidazole (NAI-N3) modifies all four nucleotides equally. The NAI-N3 is then biotinylated.||Yes, using streptavidin beads that bind biotin||Yes||Yes|